EpiVax Announces Laboratory Expansion and Streamlined, NAM-Centric In Vitro Services
- Written by PR Newswire
![]() |
PROVIDENCE, R.I., June 23, 2026 /PRNewswire/ -- EpiVax, Inc., a recognized leader in immunogenicity risk assessment, announces the expansion of its laboratory facilities at its Providence, RI headquarters. The upgraded space has more than doubled the company's laboratory footprint, expanding the CRO's capacity to support advanced...
Read more: EpiVax Announces Laboratory Expansion and Streamlined, NAM-Centric In Vitro Services















